CCM
TMO icon

Colorado Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Colorado Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-479
Closed -$235K – 108
2026
Q1 		$235K Hold
479
– – 0.09% 96
2025
Q4 		$278K Hold
479
– – 0.1% 91
2025
Q3 		$232K Hold
479
– – 0.09% 97
2025
Q2 		$194K Hold
479
– – 0.08% 100
2025
Q1 		$238K Sell
479
-8
-2% -$4.33K 0.11% 88
2024
Q4 		$253K Sell
487
-127
-21% -$69.8K 0.12% 83
2024
Q3 		$380K Sell
614
-13
-2% -$7.7K 0.19% 76
2024
Q2 		$347K Sell
627
-7
-1% -$4.01K 0.19% 80
2024
Q1 		$368K Sell
634
-9
-1% -$5.05K 0.21% 69
2023
Q4 		$341K Sell
643
-84
-12% -$40.7K 0.22% 60
2023
Q3 		$368K Hold
727
– – 0.28% 55
2023
Q2 		$379K Buy
727
+1
+0.1% +$540 0.28% 53
2023
Q1 		$418K Sell
726
-33
-4% -$18.6K 0.32% 52
2022
Q4 		$417K Sell
759
-47
-6% -$24.9K 0.35% 49
2022
Q3 		$408K Hold
806
– – 0.35% 47
2022
Q2 		$438K Hold
806
– – 0.36% 47
2022
Q1 		$476K Hold
806
– – 0.34% 47
2021
Q4 		$541K Sell
806
-11
-1% -$6.87K 0.36% 46
2021
Q3 		$466K Sell
817
-291
-26% -$160K 0.33% 50
2021
Q2 		$558K Sell
1,108
-1
-0.1% -$472 0.38% 48
2021
Q1 		$506K Buy
1,109
+250
+29% +$119K 0.36% 48
2020
Q4 		$399K Hold
859
– – 0.29% 53
2020
Q3 		$379K Sell
859
-191
-18% -$78.9K 0.31% 51
2020
Q2 		$378K Hold
1,050
– – 0.33% 51
2020
Q1 		$297K Sell
1,050
-90
-8% -$28.4K 0.28% 53
2019
Q4 		$370K Sell
1,140
-263
-19% -$79.7K 0.26% 57
2019
Q3 		$408K Hold
1,403
– – 0.31% 56
2019
Q2 		$412K Buy
+1,403
New +$386K 0.31% 57

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Colorado Capital Management's TMO Position: Q2 2026 in Review

Colorado Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 479 shares — an estimated $235K sold.

Colorado Capital Management first reported a position in TMO in Q2 2019 and held it in 28 quarters. The position peaked at $558K in Q2 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Colorado Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Colorado Capital Management sold 479 Thermo Fisher Scientific shares in Q2 2026, an estimated $235K.
  • Colorado Capital Management first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 28 quarters.
  • Colorado Capital Management's Thermo Fisher Scientific position peaked at $558K in Q2 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Colorado Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.